Immune-related Adverse Event Laryngitis in Durvalumab-treated Hilar Cholangiocarcinoma

被引：0

作者：

Morita, Shinichi ^{[1
]}

Kumaki, Daisuke

Sakai, Takeshi

Funakoshi, Kazuhiro

机构：

[1] Niigata Prefectural Cent Hosp, Dept Gastroenterol & Hepatol, Joetsu, Japan

来源：

关键词：

Hilar cholangiocarcinoma; immune-related adverse event; laryngitis; immune checkpoint inhibitor; Durvalumab; prednisolone;

D O I：

10.2169/internalmedicine.4870-24

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：2